TranslatePolitics.com

Recent debates

8 latest topics

09-03 Protect Economic and Academic Freedom Act of 2026 13 statements 09-03 Moment of Silence in Honor of the 25th Anniversary of September 11 2 statements 09-03 Honoring Former U.S. Representative Charles Hatcher of Georgia 2 statements 09-03 Recognizing Firefighters from California's Third Congressional District 17 statements 09-02 Saluting White Plains Beautification Foundation 2 statements 09-02 Celebrating Rural Lawyer Julie Bear 4 statements 09-02 Operation Midway Blitz Anniversary 2 statements 09-02 Catherine Watts Celebrates 100th Birthday 4 statements

House of Representatives

FDA Modernization Act 3.0

2026-07-20 Issue 118 Showing 1–2 of 2

Official Congressional Record ↗

Frank Pallone, Jr.

Democrat 2:50 p.m.

“I like this bill. I want the government to say 'nonclinical' instead of 'animal' in its rules. This will match a law passed last year that lets researchers use other ways to test drugs. I want everyone to vote yes on this bill.”

Official Congressional Record

Mr. Speaker, I yield myself such time as I may consume. Mr. Speaker, I rise in support of H.R. 2821, the FDA Modernization Act 3.0, led by Representative Barragan and Representative Carter of Georgia. The FDA Modernization Act 3.0 would require the Food and Drug Administration to update regulations to replace references to animal tests, data, studies, models, and research in specified sections of Title 21 of the Code of Federal Regulations with references to nonclinical tests. This would bring FDA's regulations in line with a law passed in 2022 that allowed for alternatives to animal testing in drug development, including those that leverage recent scientific advancements, such as computer modeling and cell-based assays. I encourage all my colleagues to vote ``yes'' on H.R. 2821, and I reserve the balance of my time.

View on ourcommons.ca ↗

Troy A. Carter

Democrat 2:50 p.m.

“I support this bill. It will make the FDA use less animal testing. The last bill did not go far enough. We need to do more to protect animals. This bill is good for patients and innovation too. Everyone should vote yes on this bill.”

Official Congressional Record

Mr. Speaker, I rise in strong support of H.R. 2821, the FDA Modernization Act 3.0, introduced by the gentleman from Georgia (Mr. Carter). I am proud to co-lead this bill with him and a bipartisan group of my colleagues: Representatives Barragan, Buchanan, DeLauro, and Harshbarger. Over 3 years ago, the FDA Modernization Act 2.0 was signed into law, allowing the agency to approve human drugs without requiring animal testing through modern, often more effective, alternatives. Despite this progress, the FDA has still not issued updated regulations to clarify where alternatives to animal testing are, in fact, permissible. This legislation takes action to close the gap by requiring the FDA to fully implement the reforms that Congress has already enacted and to help reduce unnecessary animal testing in drug development. By ensuring the full implementation of the FDA Modernization Act 2.0, this legislation will help modernize and transform drug development for the 21st century; accelerate safer, more effective medical breakthroughs; and advance more humane scientific research. This is long overdue. We see the unnecessary slaughtering of animals for research when there are other alternatives that may be, in fact, more humane, more effective, and more cost effective, yet we continue to do the same thing as if. I am proud to be a part of this bill that will go a long way toward protecting lives, advancing technological scientific finds, and creating a better, more humane system. Overall, our bill is a big win for patients, a big win for innovation, and a big win for animal welfare. Mr. Speaker, I encourage all my colleagues to vote ``yes'' on passing this critical legislation.

View on ourcommons.ca ↗

What they said. What they meant.

Recent debates